Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Rosewell

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Therapy. Methods & Clinical Development|January 1, 2020
Immunology of Adenoviral Vectors in Cancer TherapyAmanda Rosewell Shaw, Masataka Suzuki
Current Opinion in Virology|July 6, 2016
Recent advances in oncolytic adenovirus therapies for cancerAmanda Rosewell Shaw, Masataka Suzuki
Frontiers in Immunology|October 10, 2018
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor TreatmentAmanda Rosewell Shaw, Masataka Suzuki
Journal of Genetic Syndromes & Gene Therapy|February 18, 2014
Helper-Dependent Adenoviral VectorsAmanda Rosewell, Francesco Vetrini, Philip Ng
Cancers|March 12, 2020
Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future PerspectivesMary K McKenna, Amanda Rosewell-Shaw, Masataka Suzuki
Molecular Therapy Oncolytics|December 23, 2021
Current development in adenoviral vectors for cancer immunotherapyGreyson Willis Grossman Biegert, Amanda Rosewell Shaw, Masataka Suzuki
Frontiers in Immunology|June 24, 2025
Alternative splicing of KLF4 in myeloid cells: implications for cellular plasticity and trained immunity in cancer and inflammatory diseaseAmanda Rosewell Shaw, Attoria Bennett, Daping Fan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2020
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer TreatmentNorihiro Watanabe, Mary Kathryn McKenna, Amanda Rosewell Shaw, et al.
Cancers|June 10, 2022
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer ImmunotherapyAmanda Rosewell Shaw, Caroline Porter, Greyson Biegert, et al.
Cancer Research|February 26, 2017
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid TumorsKiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Methods & Clinical Development|January 1, 2020
Immunology of Adenoviral Vectors in Cancer TherapyAmanda Rosewell Shaw, Masataka Suzuki
Current Opinion in Virology|July 6, 2016
Recent advances in oncolytic adenovirus therapies for cancerAmanda Rosewell Shaw, Masataka Suzuki
Frontiers in Immunology|October 10, 2018
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor TreatmentAmanda Rosewell Shaw, Masataka Suzuki
Journal of Genetic Syndromes & Gene Therapy|February 18, 2014
Helper-Dependent Adenoviral VectorsAmanda Rosewell, Francesco Vetrini, Philip Ng
Cancers|March 12, 2020
Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future PerspectivesMary K McKenna, Amanda Rosewell-Shaw, Masataka Suzuki
Molecular Therapy Oncolytics|December 23, 2021
Current development in adenoviral vectors for cancer immunotherapyGreyson Willis Grossman Biegert, Amanda Rosewell Shaw, Masataka Suzuki
Frontiers in Immunology|June 24, 2025
Alternative splicing of KLF4 in myeloid cells: implications for cellular plasticity and trained immunity in cancer and inflammatory diseaseAmanda Rosewell Shaw, Attoria Bennett, Daping Fan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2020
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer TreatmentNorihiro Watanabe, Mary Kathryn McKenna, Amanda Rosewell Shaw, et al.
Cancers|June 10, 2022
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer ImmunotherapyAmanda Rosewell Shaw, Caroline Porter, Greyson Biegert, et al.
Cancer Research|February 26, 2017
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid TumorsKiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Pageof 2